Evaluation of the Epigenetic Demethylation of NRF2, a Master Transcription Factor for Antioxidant Enzymes, in Colorectal Cancer
Open Access
- 1 May 2020
- journal article
- research article
- Published by CMV Verlag in Reports of Biochemistry and Molecular Biology
- Vol. 9 (1) , 33-39
Abstract
Background: Epigenetic changes in CpG islands of the promoter regions of homeostasis-related genes, including nuclear factor erythroid 2-related factor 2 (NRF2), have been shown to hold a significant role in the development of colorectal cancer. Therefore, we aimed to examine the DNA demethylation pattern of the NRF2 promoter region in cancerous lesions ...Keywords
This publication has 31 references indexed in Scilit:
- Genetic pathways linking hemostasis and cancerThrombosis Research, 2012
- CpG islands and the regulation of transcriptionGenes & Development, 2011
- Primary Prevention of Colorectal CancerGastroenterology, 2010
- Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous LesionsPLOS ONE, 2010
- Nrf2 Expression Is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP MicePLOS ONE, 2010
- Epigenetics in cancerCarcinogenesis, 2009
- Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cellsEuropean Journal of Cancer, 2009
- A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activityBiochemical and Biophysical Research Communications, 2007
- Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung CancerPLOS Medicine, 2006
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988